Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the c ...

Jupiter Endovascular has completed patient enrolment in the SPIRARE II pivotal clinical trial of its Vertex pulmonary ...

Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.

Life Time Group Holdings, Inc. ("Life Time" or the "Company") today announced the participation information for its fourth quarter and full-year 2025 earnings conference call. The date was previously ...

Bluesight, the leader in health system intelligence solutions, today announced that two of its most widely used offerings ? ControlCheck and PrivacyPro ? have been recognized in the 2026 Best in KLAS ...

Jupiter Endovascular completes enrollment in a pivotal trial of its Vertex system with Transforming Fixation technology for ...

Abstract: Endovascular surgeries generally rely on push-based catheters and guidewires, which require significant training to master and can still result in high stress being exerted on the anatomy, ...

Moderator Kenneth Rosenfield, MD, MHCDS, leads an expert conversation on sustaining PERT programs, preventing burnout, reducing therapeutic bias, integrating AI, and improving patient-centered PE care ...

Abstract: Endovascular procedures have revolutionized vascular disease treatment, yet their manual execution is challenged by the demands for high precision, operator fatigue, and radiation exposure.

Over the years, passing spacecraft have observed mystifying weather patterns at the poles of Jupiter and Saturn. The two planets host very different types of polar vortices, which are huge atmospheric ...

With the moon out of the way on Jan. 18, bright Jupiter and Saturn become stand-outs in the January night sky. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...